Tropical Journal of Pharmaceutical Research

Original Research Article | OPEN ACCESS

Self-Nanoemulsifying Drug Delivery Systems Based on Melon Oil and its Admixture with a Homolipid from Bos indicus for the Delivery of Indomethacin

Nicholas C Obitte¹, Kenneth C Ofokansi² , Ifeanyi T Nzekwe³, Charles O Esimone⁴, Ifeanyi E Okoye³

¹Department of Pharmaceutical Technology; ²Department of Pharmaceutics, University of Nigeria, Nsukka; ³Department of Pharmaceutics and Pharmaceutical Technology; ⁴Department of Pharmaceutical Microbiology and Biotechnology, Nnamdi Azikiwe University, Awka, Nigeria.

For correspondence:- Kenneth Ofokansi Email: kcofokansi@yahoo.com Tel:+2348131245821

Received: 12 August 2010 Accepted: 19 April 2011 Published: 24 June 2011

Citation: Obitte NC, Ofokansi KC, Nzekwe IT, Esimone CO, Okoye IE. Self-Nanoemulsifying Drug Delivery Systems Based on Melon Oil and its Admixture with a Homolipid from Bos indicus for the Delivery of Indomethacin. Trop J Pharm Res 2011; 10(3):299-307 doi: 10.4314/tjpr.v10i3.11

© 2011 The authors.
This is an Open Access article that uses a funding model which does not charge readers or their institutions for access and distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0) and the Budapest Open Access Initiative (http://www.budapestopenaccessinitiative.org/read), which permit unrestricted use, distribution, and reproduction in any medium, provided the original work is properly credited..

Abstract

Purpose: To formulate self-nanoemulsifying drug delivery systems (SNEDDS) based on melon oil and its admixture with a homolipid from Bos indicus (cow fat) for the delivery of indomethacin, a hydrophobic anti-inflammatory agent.

Method: Melon oil and cow fat were extracted by standard methods and used in the formulation of SNEDDS based on either melon oil alone, or its admixture with cow fat by utilizing varying ratios of oil(s), surfactants and co-surfactants, with or without carbosil, a glidant. The formulations were encapsulated in hard gelatin capsules and then evaluated using relevant parameters including isotropicity tests, dilution stability, precipitation propensity, emulsification time, absolute drug content, in vitro drug release, and anti-inflammatory activity in an animal model.

Results: Stable and negatively charged colloidal dispersions (zeta potential: -10.4 to -13.4 mV) in the nano size range (195 - 210 nm) were formed. Formulation of indomethacin as SNEDDS not only preserved the activity of the drug, but also guaranteed anti-inflammatory activity comparable to that of indomethacin injection. The inhibition produced by the drug-loaded SNEDDS and the positive control were identical for much of the 5 h test period, indicating a high degree of bioavailability of the administered SNEDDS formulation.

Conclusion: A 1:1 ratio of melon oil and cow fat could be used in the formulation and delivery of indomethacin-loaded SNEDDS with satisfactory properties and acceptable product performance. The anti-inflammatory activity of indomethacin was preserved in the formulation.

Keywords: Melon oil; Cow fat; Drug release; Indomethacin; Self-nanoemulsifying systems; Surfactants